本文へスキップ
MediHelp
MediHelp 医薬品リファレンス

医薬品リファレンス

Somapacitan

Somapacitan is a medicine in the class endocrine. It is used for growth failure.

最終更新日 出典: US FDA label

医療従事者向け・参照専用。このページは簡潔な要約であり、医学的助言ではなく、公式の添付文書や臨床判断に代わるものではありません。処方・調剤の前に必ず確認してください。

このページの臨床コンテンツは英語でのみ提供されています。

要点

薬効分類
Endocrine
ATCコード
H01AC07
一般的な剤形
注射剤
既知の相互作用
101 (中等度: 62 · 軽度: 39)
商品名
2
国・市場
2

剤形、規格、商品名は国によって異なります。お手元の製品をご確認ください。

何に使われるか

作用のしくみ

Somapacitan-beco binds to a dimeric GH receptor on target cells, causing intracellular signal transduction. Some effects are mediated mainly by IGF-1 produced in the liver, others are direct effects of somapacitan-beco.

成人の通常用量（添付文書の要約）

Adult GHD: start 1.5 mg subcutaneously once weekly (treatment-naive or switching from daily GH); increase every 2 to 4 weeks by approximately 0.5 mg to 1.5 mg based on clinical response and IGF-1; maximum 8 mg once weekly

添付文書の最初の用法・用量の行のみの要約です。用法・用量の全項目はアプリでご覧いただけます。

妊娠と授乳

妊娠
Unknown No data for this long-acting growth hormone; decades of short-acting growth hormone use in pregnancy show no drug-related risk, and animals showed no birth defects. UK label: not recommended in pregnancy or without contraception. Growth hormone is usually stopped once pregnancy is confirmed.
授乳
Unknown No human data; it passes into rat milk. UK label: decide whether to stop breastfeeding or the drug. LactMed: a large, poorly absorbed molecule unlikely to reach the infant, but with no experience an alternative may be preferred with a newborn or preterm infant.

報告されている副作用

  • Nasopharyngitis
  • Headache
  • Pyrexia
  • Pain in extremity
  • Injection site reaction
  • Cough

禁忌

  • Acute critical illness after open-heart surgery, abdominal surgery or multiple accidental trauma, or acute respiratory failure
  • Hypersensitivity to SOGROYA or any of its excipients
  • Pediatric patients with closed epiphyses

注意が必要な方

  • Increased mortality in acute critical illness
  • Severe hypersensitivity including anaphylaxis and angioedema may occur
  • Neoplasm risk: monitor patients with preexisting tumors; second neoplasm risk in childhood cancer survivors

妊娠中または授乳中であること、腎臓や肝臓の病気、アレルギー、ほかに使用しているすべての薬やサプリメントについて、薬剤師または医師にお伝えください。

主な相互作用 (101)

All 101 interactions, with severity and what to do

Pro+会員向け

ページ全体を見る

アカウントを作成してPro+トライアルを始めると、Somapacitanの完全なモノグラフ（用量、妊娠・授乳、副作用、警告、すべての相互作用）を表示できます。

  • Dosing by age, kidney and liver function, and further dose lines
  • Renal and hepatic dose adjustments
  • Paediatric dosing
  • Dosing in older adults
  • How to give it
  • Pharmacokinetics
  • Patient counselling points
無料アカウントを作成 ログイン

WebでPro+を14日間無料でお試し。カード登録不要。

同じ分類のほかの薬剤

よくある質問

What is Somapacitan used for?

Somapacitan is a medicine in the class endocrine. It is used for Growth failure, Growth hormone deficiency.

What side effects have been reported with Somapacitan?

Nasopharyngitis, Headache, Pyrexia, Pain in extremity, Injection site reaction, Cough.

Can Somapacitan be taken in pregnancy or while breastfeeding?

Pregnancy: Unknown. No data for this long-acting growth hormone; decades of short-acting growth hormone use in pregnancy show no drug-related risk, and animals showed no birth defects. UK label: not recommended in pregnancy or without contraception. Growth hormone is usually stopped once pregnancy is confirmed. Breastfeeding: Unknown. No human data; it passes into rat milk. UK label: decide whether to stop breastfeeding or the drug. LactMed: a large, poorly absorbed molecule unlikely to reach the infant, but with no experience an alternative may be preferred with a newborn or preterm infant.

What does Somapacitan interact with?

MediHelp lists 101 known interactions for Somapacitan. Moderate: 62 · Minor: 39. The most serious include Alogliptin, Alogliptin-metformin, Alogliptin-pioglitazone.

完全なモノグラフ、用量、相互作用チェッカーはMediHelpアプリで

MediHelpアプリで、完全なリファレンスを開き、複数薬剤の相互作用をチェックし、用量ツールを利用できます。

ダウンロード：App Store 入手：Google Play

A–Zで探す · 医薬品リファレンス

アプリを入手 ログイン